P.-A. Fischer

1.1k total citations
40 papers, 696 citations indexed

About

P.-A. Fischer is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Aerospace Engineering. According to data from OpenAlex, P.-A. Fischer has authored 40 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Aerospace Engineering. Recurrent topics in P.-A. Fischer's work include Parkinson's Disease Mechanisms and Treatments (24 papers), Neurological disorders and treatments (14 papers) and Parkinson's Disease and Spinal Disorders (6 papers). P.-A. Fischer is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (24 papers), Neurological disorders and treatments (14 papers) and Parkinson's Disease and Spinal Disorders (6 papers). P.-A. Fischer collaborates with scholars based in Germany. P.-A. Fischer's co-authors include H. Baas, E. Schneider, Thomas Paffrath, Marc Maegele, Arasch Wafaisade, Rolf Lefering, Sebastian Wutzler, Pedro Roberto Jacobi, C. Simanski and Thorsten Tjardes and has published in prestigious journals such as Neurology, Journal of the Neurological Sciences and Journal of Neurology.

In The Last Decade

P.-A. Fischer

36 papers receiving 646 citations

Peers

P.-A. Fischer

NEURO

CCICM

CMN

SURGE

M∘ Pinaud France

Richard S. Matteo United States

Henry L. Price United States

Mioara D. Manole United States

SM Cobbe United Kingdom

E. Gordon Sweden

M. Bredgaard Sørensen Denmark

C. Philip Larson United States

Paul J. Hoehner United States

Robert G. Merin United States

M∘ Pinaud France

P.-A. Fischer

134 ×0.4

NEURO

64 ×0.3

164 ×0.8

CCICM

69 ×0.6

CMN

502 ×5.3

SURGE

Citations per year, relative to P.-A. Fischer P.-A. Fischer (= 1×) peers M∘ Pinaud

Countries citing papers authored by P.-A. Fischer

Since Specialization

Citations

This map shows the geographic impact of P.-A. Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.-A. Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.-A. Fischer more than expected).

Fields of papers citing papers by P.-A. Fischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.-A. Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.-A. Fischer. The network helps show where P.-A. Fischer may publish in the future.

Co-authorship network of co-authors of P.-A. Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of P.-A. Fischer. A scholar is included among the top collaborators of P.-A. Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.-A. Fischer. P.-A. Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schätzle, Philipp, et al.. (2024). Noise-induced cochlear synaptopathy in C57BL/6 N mice as a function of trauma strength: ribbons are more vulnerable than postsynapses. Frontiers in Cellular Neuroscience. 18. 1465216–1465216. 3 indexed citations

Maegele, Marc, Rolf Lefering, Arasch Wafaisade, et al.. (2010). Revalidation and update of the TASH‐Score: a scoring system to predict the probability for massive transfusion as a surrogate for life‐threatening haemorrhage after severe injury. Vox Sanguinis. 100(2). 231–238. 114 indexed citations

Wafaisade, Arasch, Rolf Lefering, Thorsten Tjardes, et al.. (2009). Acute Coagulopathy in Isolated Blunt Traumatic Brain Injury. Neurocritical Care. 12(2). 211–219. 158 indexed citations

Dauletbaev, Nurlan, et al.. (2009). A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis. European journal of medical research. 14(8). 352–8. 38 indexed citations

Schneider, Emma, et al.. (2008). Wirkungen oraler Memantin-Gaben auf die Parkinson-Symptomatik: Ergebnisse einer placebo-kontrollierten Multicenter-Studie. DMW - Deutsche Medizinische Wochenschrift. 109(25). 987–990. 27 indexed citations

Harder, Sebastian, et al.. (2004). Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany. European Journal of Clinical Pharmacology. 60(11). 797–805. 17 indexed citations

Zipp, Frauke, L. Demisch, Amin Derouiche, & P.-A. Fischer. (1998). Glutamine synthetase actiity in patients with Parkinson's disease. Acta Neurologica Scandinavica. 97(5). 300–302. 6 indexed citations

Abicht, Angela, Wolfgang Müller‐Felber, P.-A. Fischer, et al.. (1997). Congenital myasthenic syndromes: clinical and genetic analysis of 18 patients.. PubMed. 2(12). 515–22. 5 indexed citations

Zipp, Frauke, et al.. (1995). Lamotrigine in Parkinson's disease — a double blind study. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 10(2-3). 199–206. 14 indexed citations

10.

Baas, H., et al.. (1993). Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 5(1). 45–61. 32 indexed citations

11.

Zipp, Frauke, H. Baas, & P.-A. Fischer. (1993). Lamotrigine-antiparkinsonian activity by blockade of glutamate release?. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 5(1). 67–75. 33 indexed citations

12.

Fischer, P.-A., H. Baas, & R. E. Hefner. (1990). Treatment of parkinsonian tremor with clozapine. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 2(3). 233–238. 44 indexed citations

13.

Fischer, P.-A. & H. Baas. (1987). Preliminary Experience with Madopar HBS: Clinical Observations and Plasma Levodopa Concentrations. European Neurology. 27(1). 81–87. 5 indexed citations

14.

Baas, H., et al.. (1985). Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism. Journal of Neural Transmission. 64(1). 45–54. 5 indexed citations

15.

Friedmann, Georges, et al.. (1982). Erste klinische Erfahrungen mit einem neuen Großbildverstärker in der Thoraxdiagnostik. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 137(11). 535–539. 7 indexed citations

16.

Schneider, E. & P.-A. Fischer. (1982). Long-term experience with bromocriptine in advanced parkinsonism. Journal of Neurology. 228(4). 249–258. 4 indexed citations

17.

Schneider, E., et al.. (1979). Cerebral atrophy and long-term response to levodopa in Parkinson's disease. Journal of Neurology. 222(1). 37–43. 4 indexed citations

18.

Schneider, E., et al.. (1979). The course of brain atrophy in Parkinson's disease. European Archives of Psychiatry and Clinical Neuroscience. 227(1). 89–95. 7 indexed citations

19.

Schneider, E., et al.. (1977). Relationship between arteriosclerosis and cerebral atrophy in parkinson's disease. Journal of Neurology. 217(1). 11–16. 6 indexed citations

20.

Fischer, P.-A., et al.. (1971). Verlaufsuntersuchungen während der L-Dopa-Therapie des Parkinson-Syndroms. Pharmacopsychiatry. 4(3). 136–148. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact